Toll Free: 1-888-928-9744

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016

Published: Mar 11, 2016 | Pages: 63 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 6 2 Introduction 7 2.1 Arteriotomy Closure Devices Overview 7 3 Products under Development 8 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment 9 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory 10 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials 13 4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies 14 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15 5 Arteriotomy Closure Devices Companies and Product Overview 16 5.1 Aporo Biomedical, Inc. Company Overview 16 5.1.1 Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16 5.2 CardioDex Ltd. Company Overview 18 5.2.1 CardioDex Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18 5.3 CloSys Corporation Company Overview 20 5.3.1 CloSys Corporation Pipeline Products & Ongoing Clinical Trials Overview 20 5.4 Cook Medical Incorporated Company Overview 22 5.4.1 Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 22 5.5 CPC of America, Inc. Company Overview 23 5.5.1 CPC of America, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.6 Essential Medical LLC Company Overview 25 5.6.1 Essential Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 25 5.7 Harvard University Company Overview 30 5.7.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 30 5.8 InSeal Medical Ltd. Company Overview 32 5.8.1 InSeal Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32 5.9 ProMed, Inc. Company Overview 36 5.9.1 ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36 5.10 Rex Medical, L.P. Company Overview 37 5.10.1 Rex Medical, L.P. Pipeline Products & Ongoing Clinical Trials Overview 37 5.11 Transluminal Technologies LLC Company Overview 38 5.11.1 Transluminal Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 38 5.12 University of Rochester Company Overview 40 5.12.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 40 5.13 Vascular Closure Systems, Inc. Company Overview 41 5.13.1 Vascular Closure Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 5.14 Vascular Solutions, Inc. Company Overview 45 5.14.1 Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45 5.15 Vasorum Limited Company Overview 47 5.15.1 Vasorum Limited Pipeline Products & Ongoing Clinical Trials Overview 47 5.16 Vivasure Medical Ltd. Company Overview 51 5.16.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51 6 Arteriotomy Closure Devices- Recent Developments 54 7 Appendix 60 7.1 Methodology 60 7.2 About GlobalData 62 7.3 Contact Us 63 7.4 Disclaimer 63
List of Tables
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8 Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9 Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10 Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11 Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12 Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13 Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14 Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15 Table 9: Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16 Table 10: Femoral Artery Closure Device - Product Status 17 Table 11: Femoral Artery Closure Device - Product Description 17 Table 12: CardioDex Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18 Table 13: EpiClose Plus - Product Status 19 Table 14: EpiClose Plus - Product Description 19 Table 15: CloSys Corporation Pipeline Products & Ongoing Clinical Trials Overview 20 Table 16: CloSys HD - Product Status 21 Table 17: CloSys HD - Product Description 21 Table 18: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 22 Table 19: X-Port Vascular Access Closure Device - Product Status 22 Table 20: X-Port Vascular Access Closure Device - Product Description 22 Table 21: CPC of America, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 Table 22: MedClose - Product Status 24 Table 23: MedClose - Product Description 24 Table 24: Essential Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 25 Table 25: MANTA - Product Status 25 Table 26: MANTA - Product Description 25 Table 27: X-Seal - Product Status 26 Table 28: X-Seal - Product Description 26 Table 29: Essential Medical LLC - Ongoing Clinical Trials Overview 27 Table 30: X-Seal - X-Seal 6F Vascular Closure Device EU Post-market Clinical Follow-up Protocol 28 Table 31: MANTA - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device 29 Table 32: MANTA - EU Studies for MANTA Large Bore Vascular Closure Device 29 Table 33: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 30 Table 34: Access-Closure Device - Product Status 31 Table 35: Access-Closure Device - Product Description 31 Table 36: InSeal Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 37: InSeal Intravascular Closure Device - Product Status 33 Table 38: InSeal Intravascular Closure Device - Product Description 33 Table 39: InSeal Medical Ltd. - Ongoing Clinical Trials Overview 34 Table 40: InSeal Intravascular Closure Device - InSeal Vascular Closure Device Clinical Study Protocol 35 Table 41: InSeal Intravascular Closure Device - InSeal VCD Large Bore Vascular Closure Device Clinical Study 35 Table 42: ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36 Table 43: Large Hole Closure Device - Product Status 36 Table 44: Large Hole Closure Device - Product Description 36 Table 45: Rex Medical, L.P. Pipeline Products & Ongoing Clinical Trials Overview 37 Table 46: Auto-Close Vascular Sealing System - Product Status 37 Table 47: Auto-Close Vascular Sealing System - Product Description 37 Table 48: Transluminal Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 38 Table 49: Velox CD - Product Status 39 Table 50: Velox CD - Product Description 39 Table 51: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 40 Table 52: Vascular Closure Device - Product Status 40 Table 53: Vascular Closure Device - Product Description 40 Table 54: Vascular Closure Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 Table 55: FastSeal Bioabsorbable Vascular Access Closure System - Product Status 42 Table 56: FastSeal Bioabsorbable Vascular Access Closure System - Product Description 42 Table 57: FastSeal Self - Closing Nitinol Clip System - Product Status 43 Table 58: FastSeal Self - Closing Nitinol Clip System - Product Description 43 Table 59: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Status 44 Table 60: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Description 44 Table 61: Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45 Table 62: Magna Seal - Product Status 46 Table 63: Magna Seal - Product Description 46 Table 64: Vasorum Limited Pipeline Products & Ongoing Clinical Trials Overview 47 Table 65: Celt ACD - Product Status 48 Table 66: Celt ACD - Product Description 48 Table 67: Vasorum Limited - Ongoing Clinical Trials Overview 49 Table 68: Celt ACD - Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003 50 Table 69: Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51 Table 70: PerQseal - Product Status 51 Table 71: PerQseal - Product Description 51 Table 72: Vivasure Medical Ltd. - Ongoing Clinical Trials Overview 52 Table 73: PerQseal - Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER I Study 53 Table 74: PerQseal - Safety and Performance Study of Large Hole Vascular Closure Device: FRONTIER II Study 53 Table 75: Glossary 61


List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8 Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9 Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10 Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11 Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12 Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify